GUIDA, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 9.123
NA - Nord America 7.279
AS - Asia 3.412
SA - Sud America 913
AF - Africa 133
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.876
Nazione #
US - Stati Uniti d'America 7.138
IT - Italia 6.623
SG - Singapore 1.485
CN - Cina 782
BR - Brasile 719
HK - Hong Kong 412
SE - Svezia 381
NL - Olanda 336
RU - Federazione Russa 314
DE - Germania 287
UA - Ucraina 260
FR - Francia 246
VN - Vietnam 222
FI - Finlandia 209
GB - Regno Unito 196
IN - India 95
AR - Argentina 73
BD - Bangladesh 68
CA - Canada 58
PL - Polonia 52
MX - Messico 45
TR - Turchia 43
ID - Indonesia 40
ZA - Sudafrica 39
BE - Belgio 37
IQ - Iraq 36
PK - Pakistan 36
JP - Giappone 32
CH - Svizzera 28
ES - Italia 28
CI - Costa d'Avorio 26
EC - Ecuador 24
VE - Venezuela 24
UZ - Uzbekistan 22
AT - Austria 21
CO - Colombia 19
IE - Irlanda 19
CL - Cile 16
MA - Marocco 16
PH - Filippine 14
PY - Paraguay 14
SA - Arabia Saudita 14
IR - Iran 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
LT - Lituania 12
AL - Albania 11
AU - Australia 11
JO - Giordania 11
MY - Malesia 11
TN - Tunisia 10
AZ - Azerbaigian 9
JM - Giamaica 9
KZ - Kazakistan 9
BO - Bolivia 8
EG - Egitto 8
RO - Romania 7
UY - Uruguay 7
DK - Danimarca 6
KE - Kenya 6
PS - Palestinian Territory 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
HR - Croazia 5
KR - Corea 5
LU - Lussemburgo 5
NP - Nepal 5
PE - Perù 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
PA - Panama 4
SN - Senegal 4
TW - Taiwan 4
BG - Bulgaria 3
BW - Botswana 3
DZ - Algeria 3
GR - Grecia 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
TH - Thailandia 3
BY - Bielorussia 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SR - Suriname 2
SY - Repubblica araba siriana 2
ZW - Zimbabwe 2
Totale 20.857
Città #
Singapore 816
Chandler 662
Ashburn 621
Rome 551
Fairfield 519
Jacksonville 505
Woodbridge 485
San Jose 436
Hong Kong 409
Ann Arbor 317
Milan 292
Nyköping 259
Houston 249
Bari 237
Cambridge 222
Seattle 204
Beijing 199
Wilmington 185
Naples 163
New York 162
Lawrence 131
Roxbury 131
Nanjing 128
Lauterbourg 126
Los Angeles 114
Bologna 109
Boardman 95
Dallas 88
Catania 87
Des Moines 85
Inglewood 83
Helsinki 78
Ho Chi Minh City 73
Florence 67
São Paulo 65
Napoli 57
Princeton 51
Santa Clara 49
Padova 46
Turin 44
Council Bluffs 43
Brooklyn 42
Taranto 37
Buffalo 36
Hanoi 34
Munich 34
Parma 34
London 32
Nanchang 31
Tokyo 31
Hebei 30
Dong Ket 29
Brussels 28
Tianjin 28
Dearborn 27
Abidjan 26
Nuremberg 26
Palermo 26
Rio de Janeiro 26
Jakarta 24
San Diego 24
Torino 24
Warsaw 24
Belo Horizonte 23
Lucca 23
Perugia 23
Jiaxing 22
Messina 22
Orem 22
Salerno 22
Cagliari 21
Denver 21
Ferrara 21
Pescara 21
Caserta 20
Falkenstein 20
Genoa 20
Johannesburg 20
Pisa 20
Shenyang 20
Tashkent 20
Verona 20
Brescia 19
Chicago 19
San Francisco 19
Toronto 19
Changsha 18
Frankfurt am Main 18
Manchester 18
Redwood City 17
Stockholm 17
Dublin 16
Latina 16
Mottola 16
Reggio Calabria 16
Baghdad 15
Chennai 15
Guangzhou 15
Lahore 15
Montreal 15
Totale 10.600
Nome #
FOSFORILAZIONE DEL FATTORE DI INIZIO DELLA TRADUZIONE eIF2 IN LINEE CELLULARI DI MELANOMA 7.138
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. 222
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells 205
Influence of melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of patients with metastatic melanoma harboring the BRAF mutation and treated with BRAF inhibitors 195
Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants 191
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy 187
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α 187
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 178
ANALISI MOLECOLARE E FUNZIONALE DEL RECETTORE MC1R NEL MELANOMA MALIGNO 175
MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors 156
Metastatic melanoma cells with BRAF G469A mutation: nab‑paclitaxel better than vemurafenib? 154
Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib 154
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project 148
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale) 147
NEW HORIZONS IN TREATMENTS OF METASTATIC MELANOMA: THE ROLE OF TOMATINE 147
Amphibian Kupffer Cells: TyrosinaseGene Expression 144
Negative influence of Melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of metastatic melanoma (MM) patients (pts) harboring BRAF mutation and treated with BRAF inhibitors (BRAFi) 144
Barasertib: a novel approach for the treatment of metastatic melanoma 137
ACTIVATION OF DETOXIFYING ENZYMES IN TOMATO ROOTS FOLLOWING PARAQUAT TREATMENT AND NEMATODE INFECTION 136
Spleen and liver pigmented macrophages of Rana esculenta L.A new melanogenic system? 131
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO DEI MELANOMACROFAGI 130
Three novel human sporadic melanoma cell lines: signaling pathways controlled by MC1R, BRAF and β-catenins 130
The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma 128
MC1R genotype and psoriasis: is there a link revealing a phenotypic differences? 128
Seasonal variations of Rana esculenta L. skin tyrosinase 127
A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC MELANOMA 126
Analysis of the enzymatic activity of the pigmented macrophages from liver and spleen of Rana esculenta L. 126
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort 126
The translation initiation factor eIF2 is hyperphosphorylated in melanoma cell lines 125
The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status 125
Genetic profiling of a rare condition: Co-occurrence of albinism and multiple primary melanoma in a caucasian family 124
ULTRASTRUCTURE OF THE CELL WALL OF GRACILARIA C.F. VERRUCOSA (GRACILARIALES, RHODOPHYTA): EFFECTS OF STEAM EXPLOSION 122
Metabolic reprogramming in melanoma: the role of peIF2 alpha 121
Molecular and Ultrastructural analysis of a multiphasic oral malignant Melanoma 118
Analisi delle attività enzimatiche dei melanosomi isolati dai macrofagi pigmentati di Rana esculenta L. 117
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO CUTANEO DI RANA ESCULENTA L 116
INCREASE IN RNA AND PROTEIN SYNTHESIS BY MITOCHONDRIA IRRADIATED WITH HELIUM-NEON LASER 114
The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status. 112
ACTIVATION OF DETOXIFYING ENZYMES IN TOMATO ROOTS FOLLOWING PARAQUAT TREATMENT AND NEMATODE INFECTION. NEMATOLOGIA MEDITERRANEA 112
ATTIVITA' TIROSINASICA DELLE CELLULE DI KUPFFER DI RANA ESCULENTA L 111
The next generation of metastatic melanoma: Uncovering the genetic variants for anti-BRAF therapy response 111
Attività Tirosinasica delle Cellule di Kupffer di Rana esculenta L. 110
Tyrosinase gene expression in the Kupffer Cells of Rana esculentaL 110
CHARACTERIZATION OF THE SKIN MELANOGENETIC SYSTEM OF RANA ESCULENTA L 110
MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project 110
Enhanced Delivery of 5‑Aminolevulinic Acid by Lecithin Invasomes in 3D Melanoma Cancer Model 109
Effects of alpha-MSH on the tyrosinase system in Kupffer cells of Rana esulenta L 109
Analisi delle attività enzimatiche dei melanosomi isolati dai macrofagi pigmentati di Rana esculenta L 109
THE INFLUENCE OF MC1R DERMAL MORPHOLOGICAL FEATURES OF PHOTOEXPOSED SKIN IN WOMEN REVEALED BY REFLECTANCE CONFOCAL MICROSCOPY AND OPTICAL COHERENCE TOMOGRAPHY 108
Analysis of the enzymatic activity of the pigmented macrophages from liver and spleen of Rana esculenta L 108
Amphibian Kupffer Cells: Tyrosinase Gene Expression. 108
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO DEI MELANOMACROFAGI 106
Characterization of the melanogenic system in the SHK-1 cell line from Salmo salar L. Atlantic salmon 106
Stress response pathways driving tumorigenesis in melanoma cell lines. 106
PGC1 alpha expression and correlation with BRAF mutational status 105
ANALISI MOLECOLARE E FUNZIONALE DEL RECETTORE MC1R NEL MELANOMA MALIGNO 105
Aspetti molecolari della proliferazione cellulare e della metastatizzazione nel melanoma 102
Analisi del sistema tirosinasico nella linea cellulare SHK-1 di Salmo Salar L. (Teleostei) 102
Tomatine displays antitumor potential in in vitro models of metastatic melanoma 102
Caratterizzazione del sistema melanogenetico dei melanomacrofagi epatici di Rana esculenta L. 101
Phosphorilated ERK and eIF2alpha levels in melanoma cells. 101
Melanogenic response of the Kupffer cells of Rana esculenta L to melanocyte stimulating hormone 101
Kupffer cell response to MSH in Rana esculenta L. 99
Characterization of the skin tyrosinase from Rana esculenta L 99
STUDIES ON PIGMENT CELLS FROM THE LIVER OF RANA ESCULENTA L 97
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 96
CHARACTERIZATION OF THE SKIN MELANOGENETIC SYSTEM OF RANA ESCULENTA L 95
EXPRESSION OF BASE EXCISION REPAIR KEY FACTORS AND miR17 IN FAMILIAL AND SPORADIC BREAST CANCER. 95
Correlazione tra stato mutazionale di MC1R ed outcomes clinici in pazienti (pts) affetti da melanoma metastaticoBRAF-mutati (MM) trattati con farmaci anti-BRAF 94
Molecular cloning and biochemical characterization of the skin tyrosinase from Rana esculenta L 94
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma 94
Optical and photoelectronic properties of Melanin Films. 93
Kupffer cell response to MSH in Rana esculenta L 93
Analisi del sistema tirosinasico nella linea cellulare SHK-1 di Salmo Salar L. (Teleostei) 93
Optical spectroscopy of melanin films. 91
Raman and optical spectroscopy of eumelanin films 90
HELIUM-NEON LASER IRRADIATION OF RAT LIVER MITOCHONDRIA GIVES RISE TO A NEW SUBPOPULATION OF MITOCHONDRIA: ISOLATION AND FIRST BIOCHEMICAL CHARACTERIZATION 90
Studio sui processi di proliferazione cellulare e metastatizzazione in nuove linee cellulari di melanoma. 89
High activity of the Aurora B Kinase inhibitor AZD1152 on melanoma cell lines irrespective of BRAF mutation. 87
Morphological and molecular characterization of a heterogeneous melanoma of the oral cavity 87
PGC1 alpha EXPRESSION AND CORRELATION WITH BRAF MUTATIONAL STATUS 87
Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatment 86
Association of MC1R variants with melanoma risk and interaction with sun exposure: An M-SKIP project 86
PRELIMINARY EVALUATION OF AN AGAR FRACTION OBTAINED FROM GRACILARIA VERRUCOSA 86
Control of tyrosinase gene activation by 86
Optical spectra of melanin films extracted from Rana Esculenta 85
Control of tyrosinase gene activation by - MSH in Kupffer cells of Rana esculenta L. 85
Optical Spectra of Melanin Films Extracted from Rana esculenta L 85
THE MELANOGENIC SYSTEM OF THE LIVER PIGMENTED MACROPHAGES OF RANA ESCULENTA L. TYROSINASE ACTIVITY 83
Characterization of the Skin Tyrosinase from Rana esculenta L. 83
MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project 83
Molecular characterization of novel melanoma cell lines 82
“Differentiation in vitro of the hepatic pigment cells from Rana esculenta L. 81
Profilo proteomico di pazienti BRAF wild type trattati con temozolomide 80
Studio sulle cellule pigmentate di origine istiocitaria di Rana esculenta L. Espressione in vitro del gene della tirosinasi 79
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma 76
IRISIN AND METASTATIC MELANOMA: SELECTIVE ANTI-INVASIVENESS ACTIVITY IN BRAF WILD-TYPE CELLS 76
MC1R RECEPTOR IN MALIGNANT MELANOMA: MOLECULAR AND FUNCTIONAL ANALYSIS 75
Atrophic and hypertrophic skin photoaging and melanocortin-1 receptor (MC1R): the missing link 74
Geni di suscettibilità del melanoma: revisione ed update 73
Totale 18.360
Categoria #
all - tutte 65.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021128 0 0 0 0 0 0 0 0 0 0 0 128
2021/20221.377 68 135 43 41 83 125 80 84 98 80 217 323
2022/20232.381 251 176 138 216 259 232 153 313 349 55 93 146
2023/20241.614 123 129 90 68 106 235 263 208 71 91 85 145
2024/20253.460 260 80 290 139 204 322 382 310 169 158 459 687
2025/20265.614 698 329 337 743 783 364 727 259 513 532 209 120
Totale 21.294